Search

everythinglearnresearchcommunity

for

Search:↓

The study created a new method to test drugs that affect hormone processing in skin.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

Carthamus oxyacantha may help treat BPH by inhibiting 5α-reductase.

Scientists found out the structure of a human enzyme linked to prostate cancer and hair loss, which could help in designing drugs.

Three specific 4-azasteroid-2-oximes showed strong enzyme inhibition, but less than finasteride.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

Finasteride may treat baldness but less effective for those with 5α-reductase deficiency.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

The enzyme 5α-reductase type 1 is important for blood vessel development and fertility in the uterus.

Combining 5α-reductase and aromatase inhibitors may better reduce estrogen levels.

The enzyme 5α-reductase is important for proper blood vessel development during the fertility-related transformation of the uterus lining.

Finasteride lowers DHT levels and raises testosterone in a dose-dependent way.

The main enzyme found in pubic skin that could be targeted to treat excessive hair growth is 5 alpha-R2.

Female mice with disrupted 5α-reductase 1 had significant metabolic issues, including stress response problems, insulin resistance, liver fat buildup, and obesity.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Human adrenals and gonads have a unique enzyme for steroid hormone production.

Blocking 5α-reductase can harm memory and brain structure, and increase harmful brain changes in male mice used for Alzheimer's disease research.

Human liver enzyme DHEA ST helps process minoxidil.

Accurate protein modeling can help develop new treatments for prostate cancer and other diseases.

Mutants of CYP154C2 enzyme significantly improved steroid conversion efficiency.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Norgestimate is the most effective birth control progestin for reducing an enzyme linked to acne and excessive hair growth in women.

11α-Hydroxyprogesterone is changed into different substances by certain enzymes and may play a role in prostate cancer.